• Protocols

• GOG3133

  OPEN TO ACCRUAL

  2 Part Ph 3 Sofe-M vs Chemo or MIRV in PROC, and Sofe-M + Bev vs Chemo + Bev in PSOC
  
  

• UW24116

  OPEN TO ACCRUAL

  Ph2 trial of Mirvetuximab Soravtansine and Olaparib in Ovarian Peritoneal and Fallopian Tube Cancer